Balancing Blood Sugar: A Lifeline for Older Adults with Cognitive Challenges
Discovering the optimal balance for blood sugar levels in older adults with cognitive impairments reveals a nuanced approach to diabetes management that may extend life expectancy. This research delves into how maintaining glycated hemoglobin (HbA1c) within specific target ranges can significantly influence mortality rates among this vulnerable population. By examining the outcomes for patients with type 2 diabetes attending a memory clinic, the study uncovers that those who keep their HbA1c levels neither too high nor too low, but just right, aligning with recommended guidelines, exhibit no increased risk of death compared to non-diabetic peers.
The investigation categorizes patients based on their HbA1c levels, evaluating the impact of these levels on survival over an average follow-up of 3.8 years. Remarkably, it finds that adhering to the 'goldilocks zone' of blood sugar control mitigates the heightened risk of mortality often associated with diabetes, particularly in those with cognitive impairments. This insight underscores the importance of tailored diabetes management strategies that prioritize individual health profiles and cognitive conditions.
This research is pivotal, suggesting that precise management of diabetes could be a key strategy in enhancing the quality and duration of life for older adults facing cognitive decline. It emphasizes the need for healthcare providers to consider cognitive health status when advising on diabetes management, advocating for a balance that supports both mental and physical well-being.
Article Information
Impact of Type 2 Diabetes and Glycated Hemoglobin Levels Within the Recommended Target Range on Mortality in Older Adults With Cognitive Impairment Receiving Care at a Memory Clinic: NCGG-STORIES
Published in Diabetes Care. Taiki Sugimoto et al.
Abstract
Objective: To determine the impact of type 2 diabetes and glycated hemoglobin (HbA1c) levels within the recommended target range according to the Japan Diabetes Society/Japan Geriatrics Society Joint Committee on mortality in older adults with cognitive impairment.
Research design and methods: This retrospective cohort study included 1,528 and 468 patients aged ≥65 years without and with type 2 diabetes, respectively, who were visiting a memory clinic. The 468 patients with type 2 diabetes were divided into three groups (within, above, and below the target range) based on their HbA1c levels, cognitive function, ability to perform activities of daily living, and medications associated with a high risk of hypoglycemia. The impact of diabetes and HbA1c levels on mortality was evaluated using Cox proportional hazards models.
Results: Over a median follow-up period of 3.8 years, 353 patients (17.7%) died. Compared with individuals without type 2 diabetes, HbA1c levels above (hazard ratio [HR] 1.70, 95% CI 1.08-2.69) and below (HR 2.15, 95% CI 1.33-3.48) the target range were associated with a higher risk of death; however, HbA1c levels within the target range were not (HR 1.02, 95% CI 0.77-1.36).
Conclusions: HbA1c levels above and below the target range were associated with a higher risk of mortality, whereas patients with HbA1c levels within the target range did not exhibit a higher risk of mortality than individuals without type 2 diabetes. These results provide empirical support for the current target ranges among older adults with cognitive impairment.
Bring preventive care to your clinic
© Longevity Artificial Intelligence. All rights reserved.